Glycoconjugate ExPEC vaccine: Phase I started

GlycoVaxyn began a placebo-controlled, Swiss Phase I trial to evaluate the Glycoconjugate ExPEC vaccine in 180 women affected by recurrent urinary tract infection (UTI). GlycoVaxyn and Johnson & Johns...